Methods of drug delivery in neurotrauma

Ying Deng-Bryant, Ryan Readnower, Lai Yee Leung, Frank Tortella, Deborah Shear

Research output: Chapter in Book/Report/Conference proceedingChapterpeer-review

8 Scopus citations


The central nervous system (CNS) is protected by blood–brain barrier (BBB) and blood-cerebrospinal- fluid (CSF) barrier that limit toxic agents and most molecules from penetrating the brain and spinal cord. However, these barriers also prevent most pharmaceuticals from entering into the CNS. Drug delivery to the CNS following neurotrauma is complicated. Although studies have shown BBB permeability increases in various TBI models, it remains as the key mitigating factor for delivering drugs into the CNS. The commonly used methods for drug delivery in preclinical neurotrauma studies include intraperitoneal, subcutaneous, intravenous, and intracerebroventricular delivery. It should be noted that for a drug to be successfully translated into the clinic, it needs to be administered preclinically as it would be anticipated to be administered to patients. And this likely leads to better dose selection of the drug, as well as recognition of any possible side effects, prior to transition into a clinical trial. Additionally, novel approach that is noninvasive and yet circumvents BBB, such as drug delivery through nerve pathways innervating the nasal passages, needs to be investigated in animal models, as it may provide a viable drug delivery method for patients who sustain mild CNS injury or require chronic treatments. Therefore, the focus of this chapter is to present rationales and methods for delivering drugs by IV infusion via the jugular vein, and intranasally in preclinical studies.

Original languageEnglish
Title of host publicationMethods in Molecular Biology
PublisherHumana Press Inc.
Number of pages12
StatePublished - 2016

Publication series

NameMethods in Molecular Biology
ISSN (Print)1064-3745


  • Drug delivery
  • Intranasal
  • Intravenous
  • Neurotrauma
  • Traumatic brain injury


Dive into the research topics of 'Methods of drug delivery in neurotrauma'. Together they form a unique fingerprint.

Cite this